United Therapeutics Corporation (UTHR)

Quick ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash US$ in thousands 1,207,700 1,107,700 1,067,300 1,163,500 961,200 966,800 795,200 813,300 894,800 908,500 942,200 832,300 738,700 670,200 685,400 875,200 738,400 719,700 881,300 790,600
Short-term investments US$ in thousands 1,801,300 1,784,700 1,632,000 1,721,800 1,908,200 1,685,500 1,509,000 1,550,500 1,035,900 1,191,300 1,090,300 965,300 1,096,300 910,300 875,300 669,300 747,500 850,300 904,900 814,500
Receivables US$ in thousands 278,900 258,600 272,700 134,500 220,400 231,700 173,400 170,500 198,700 212,800 173,400 141,100 157,400 152,300 172,000 149,600 151,400 183,600 181,000 159,800
Total current liabilities US$ in thousands 804,400 744,100 370,300 324,600 343,200 315,900 331,500 292,600 305,400 320,000 311,400 302,400 323,300 258,900 255,000 207,300 463,000 469,900 463,500 270,000
Quick ratio 4.09 4.23 8.03 9.30 9.00 9.13 7.47 8.66 6.97 7.23 7.08 6.41 6.16 6.69 6.79 8.17 3.54 3.73 4.24 6.54

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,207,700K + $1,801,300K + $278,900K) ÷ $804,400K
= 4.09

The quick ratio of United Therapeutics Corp has shown relatively high and stable values over the past eight quarters. The quick ratio measures the company's ability to meet its short-term obligations using its most liquid assets. A quick ratio above 1 indicates that the company has enough liquid assets to cover its current liabilities.

In Q4 2023, the quick ratio was 4.28, which indicates that the company had $4.28 in liquid assets for every $1 of current liabilities. This was slightly lower compared to the previous quarter but still at a comfortable level.

Overall, the company's quick ratio has been consistently high, ranging from 4.28 to 9.55 over the past eight quarters. This suggests that United Therapeutics Corp has a strong ability to meet its short-term obligations using its liquid assets. A high quick ratio typically indicates good liquidity and financial health, providing assurance to investors and creditors regarding the company's ability to manage its short-term financial commitments.